The FDA turns down an injectable version of Johnson & Johnson’s lung cancer cells medicine, Rybrevant.
发布者:BY MARIUS AMBAKK BJORKEDAL,转转请注明出处:https://robotalks.cn/fda-delays-approval-of-jj-lung-cancer-treatment-after-manufacturing-facility-inspection-2/